Premature skeletal muscle aging in VPS13A deficiency relates to impaired autophagy
Authors:
Open Access
- 24 April 2025
- journal article
- research article
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 13 (1) , 1-15
Abstract
VPS13A disease (chorea-acanthocytosis), is an ultra-rare autosomal recessive neurodegenerative disorder caused by mutations of the VPS13A gene encoding Vps13A. Increased serum levels of the muscle isoform of creatine kinase associated with often asymptomatic muscle pathology are among the poorly understood early clinical manifestations of VPS13A disease. Here, we carried out an integrated analysis of skeletal muscle from Vps13a−/− mice and from VPS13A disease patient muscle biopsies. The absence of Vps13A impaired autophagy, resulting in pathologic metabolic remodeling characterized by cellular energy depletion, increased protein/lipid oxidation and a hyperactivated unfolded protein response. This was associated with defects in myofibril stability and the myofibrillar regulatory proteome, with accumulation of the myocyte senescence marker, NCAM1. In Vps13a−/− mice, the impairment of autophagy was further supported by the lacking effect of starvation alone or in combination with colchicine on autophagy markers. As a proof of concept, we showed that rapamycin treatment rescued the accumulation of terminal phase autophagy markers LAMP1 and p62 as well as NCAM1, supporting a connection between impaired autophagy and accelerated aging in the absence of VPS13A. The premature senescence was also corroborated by local activation of pro-inflammatory NF-kB-related pathways in both Vps13a−/− mice and patients with VPS13A disease. Our data link for the first time impaired autophagy and inflammaging with muscle dysfunction in the absence of VPS13A. The biological relevance of our mouse findings, supported by human muscle biopsy data, shed new light on the role of VPS13A in muscle homeostasis.Keywords
Funding Information
- Hermann und Lilly Schilling-Stiftung für Medizinische Forschung
- Advocacy for Neuroacanthocytosis Patients
- U.S. Department of Veterans Affairs (CX0002342)
- Rostock Academy of Science
- FUR-UNIVR
This publication has 73 references indexed in Scilit:
- Redox regulation of UPR signalling and mitochondrial ER contact sitesCellular and Molecular Life Sciences, 2024
- Evaluating Gait and Locomotion in Rodents with the CatWalkCurrent Protocols, 2021
- Inflammaging, hormesis and the rationale for anti-aging strategiesAgeing Research Reviews, 2020
- High-Throughput Metabolomics: Isocratic and Gradient Mass Spectrometry-Based Methods2019
- The effect of lengthening contractions on neuromuscular junction structure in adult and old miceAGE, 2016
- Disruption of Nrf2/ARE signaling impairs antioxidant mechanisms and promotes cell degradation pathways in aged skeletal muscleBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Primary skeletal muscle involvement in chorea‐acanthocytosisMovement Disorders, 2007
- Nemaline rods in chorea‐acanthocytosisMuscle & Nerve, 2005
- Muscle CT scan findings in McLeod syndrome and chorea-acanthocytosisMuscle & Nerve, 2000
- “Myopathic” changes in chorea-acanthocytosisJournal of the Neurological Sciences, 1982